Library

Noopept

Noopept (omberacetam, GVS-111) is a peptide-derived nootropic first synthesized in 1996 and developed as a prescription medication in Russia. It has become one of the most widely used cognitive enhancers, often taken in combination 'stacks' with other nootropics. Noopept is commonly attributed with temporarily enhancing concentration, focus, and memory recall. Daily use may lead to dependence, with withdrawal reportedly causing negative cognitive effects.

Noopept molecular structure
Noopept molecular structure diagram from the DrugsPRO substance library.

Also known as: Gvs-111, Sgs-111, Omberacetam, N-phenylacetyl-L-prolylglycine ethyl ester, DVD-111

Classification

  • Chemical: Racetam
  • Psychoactive: Nootropic
  • Tag: Peptide
  • Tag: Peptide derivative
  • Tag: Research-Chemical

Effects

  • Spontaneous Tactile Sensations
  • Stimulation
  • Insomnia
  • Physical Energy
  • Difficulty Falling Asleep
  • Headache
  • Wakefulness
  • Thought Connectivity
  • Focus Enhancement
  • Thought Acceleration
  • Motivation Enhancement
  • Memory Enhancement
  • Acuity Enhancement
  • Color Enhancement
  • Increased Music Appreciation
  • Light Sensitivity
  • Visual Acuity Enhancement
  • Open Eye Visuals

Routes of Administration

Insufflated

Dosage

  • Light: 2 – 5 mg
  • Common: 5 – 10 mg
  • Strong: 10-20 mg
  • Threshold: 2 mg
  • Heavy: 20 mg

Duration

  • Onset: 0-0.1 h
  • Peak: 2 h
  • Offset: 3 h

Oral

Dosage

  • Heavy: 40+ mg
  • Light: 5-10 mg
  • Common: 10-20 mg
  • Strong: 10 – 20 mg
  • Threshold: 3–5 mg

Duration

  • After Effects: 0-12 h
  • Onset: 0.25-0.5 h
  • Peak: 0.75-2 h
  • Offset: 2-3 h
  • Total Duration: 3-6 h

Sublingual

Dosage

  • Light: 2 – 5 mg
  • Common: 5 – 10 mg
  • Strong: 12–20 mg
  • Threshold: 2–3 mg
  • Heavy: 20+ mg

Duration

  • Onset: 0.083-0.167 h
  • Peak: 0.5-1.5 h
  • Offset: 1.5-3 h
  • After Effects: 0-12 h
  • Total Duration: 3-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Noopept - Οδηγός ουσίας DrugsPRO

Noopept: Noopept (omberacetam, GVS-111) is a peptide-derived nootropic first synthesized in 1996 and developed as a prescription medication in Russia. It has become one of the most widely used cognitive enhancers, often taken in combination 'stacks' with other nootropics. Noopept is commonly attribu

Related pages